脂质故事:优化阿里洛米辛膜脚

Michael F T Koehler1, Yi-Chen Chen2, Yongsheng Chen3

  • 1Department of Discovery Chemistry, Genentech, Inc., South San Francisco, California 94080, United States.

PubMed
概括

新型基于阿里洛米辛的LepB抑制剂显示出对抗多药耐药格拉姆阴性细菌的前景. 优化它们的脂友部分是有效向细菌内膜和抑制SPase的关键.